Midkine and Pleiotrophin in the Treatment of Neurodegenerative Diseases and Drug Addiction

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|10|1|28-33

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.10, Iss.1, 2015-01, pp. : 28-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 171, Iss. 4, 2014-02 ,pp. : 837-848

John Wiley & Sons Inc

Access to resources Recommend Favorite

Midkine: an emerging target of drug development for treatment of multiple diseases

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 171, Iss. 4, 2014-02 ,pp. : 811-813

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Drug Addiction in Traumatised Refugees

By  

European Addiction Research, Vol. 9, Iss. 3, 2003-07 ,pp. : 144-146

Karger

Access to resources Recommend Favorite

The Treatment Strategies for Neurodegenerative Diseases by Integrative Medicine

By  

Integrative Medicine International, Vol. 1, Iss. 4, 2015-0 ,pp. : 223-225

Karger

Access to resources Recommend Favorite

Midkine in nephrogenesis, hypertension and kidney diseases

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 171, Iss. 4, 2014-02 ,pp. : 879-887

John Wiley & Sons Inc

Access to resources Recommend Favorite